EUVIMEDEUVIMED entdecken
Klinische Studie

Tinnitus: Evaluation of Intratympanic Injection of Combined Lidocaine and Corticosteroids

Saad Elzayat, Hossam El-Sherif, Hassan Hegazy, Takwa Gabr, Abdel-Rahman El-Tahan

ORL · 2016 · 78 (3) · 159-166

DOI: 10.1159/000445774 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift ORL, online erschienen am 01.06.2016. Verfasst von Saad Elzayat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Tanta University Hospital, Tanta, Egypt. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tinnitus is an annoying problem and until now there is no consensus on its treatment.

Aims

In this prospective study, we evaluated the effectiveness of intratympanic lidocaine and dexamethasone (ITLD) injections for the management of subjective idiopathic tinnitus (SIT).

Methods

Forty patients with SIT attended the Department of Otorhinolaryngology, Tanta University Hospital, Egypt, between May 2013 and May 2014. The patients were categorized into two groups: group A included 20 patients treated with ITLD injection, and group B included 20 patients treated with intratympanic saline injection as a control. Intratympanic injections were performed four times within 4 weeks in a double-blind manner. At the end of the treatment program, we analyzed the improvement and worsening rates of tinnitus using the following parameters: tinnitus questionnaires, Tinnitus Handicap Index (THI), and loudness matching test.

Results

The effectiveness rates of the ITLD group reported in the tinnitus questionnaires, the THI and the loudness matching test were 74.3% in all tests, compared to 26.7, 40.0 and 26.7%, respectively, in the saline group. There was a statistically significant difference between the groups within 2 months after injection. To analyze the therapeutic effect of ITLD on tinnitus of 6 months duration, the improvement rates reported in the tinnitus questionnaires, the THI and the loudness matching test were 78.5% in all tests in the ITLD group, compared to 40.0, 40.0 and 30.0%, respectively, in the saline group.

Conclusion

There were statistically significant differences between both groups. ITLD seems to be effective for idiopathic tinnitus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAnesthetics, LocalAudiometryDexamethasoneDouble-Blind MethodDrug Therapy, CombinationFemaleGlucocorticoidsHumansInjection, IntratympanicLidocaineMaleMiddle AgedNauseaProspective StudiesTinnitusVertigo

Substanzen

Anesthetics, LocalGlucocorticoidsDexamethasoneLidocaine

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Tanta University Hospital, Tanta, Egypt.

Zitieren

APA

Elzayat, S., El-Sherif, H., Hegazy, H., Gabr, T., & El-Tahan, A. R. (2016). Tinnitus: Evaluation of Intratympanic Injection of Combined Lidocaine and Corticosteroids. ORL, 78(3), 159-166. https://doi.org/10.1159/000445774

Vancouver

Elzayat S, El-Sherif H, Hegazy H, Gabr T, El-Tahan AR. Tinnitus: Evaluation of Intratympanic Injection of Combined Lidocaine and Corticosteroids. ORL. 2016;78(3):159-166. doi:10.1159/000445774

BibTeX
@article{Elzayat2016,
  author = {Elzayat, Saad and El-Sherif, Hossam and Hegazy, Hassan and Gabr, Takwa and El-Tahan, Abdel-Rahman},
  title = {Tinnitus: Evaluation of Intratympanic Injection of Combined Lidocaine and Corticosteroids},
  journal = {ORL},
  year = {2016},
  volume = {78},
  number = {3},
  pages = {159--166},
  doi = {10.1159/000445774}
}
Kostenlos starten →